DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen‐matched blood in patients with sickle cell disease

Abstract

Blood group genotyping by DNA array contributes to the management of transfusions in SCD patients by facilitating the transfusion support with antigen-matched blood. It has the potential to improve the life of thousands of SCD-transfused patients by reducing mortality due to transfusion reactions and immunization.